New York, USA – As an international antibody company composed of over 200 talented scientists, Creative Biolabs has devoted to bioconjugation services for over 10 years. To help academic and industrial clients to complete their project in a time-saving manner, Creative Biolabs releases antibody-antibiotic conjugate development and antibody-based probe bioconjugation services.
Antibody-drug conjugates are deemed one of the most promising methods in the immunotherapy field. Similar to antibody-drug conjugates, antibody-antibiotic conjugates (AACs) are comprised of an antibody that accurately targeting the target, an antibiotic that effectively kills bacteria and a synthetic linker that connects them, which are all irreplaceable for a successful AAC.
Equipped with years of experience, Creative Biolabs is capable of providing professional AAC development services that meet the requirements of safety, efficacy, stability, including but not limited to Antibody Discovery Services for Bacterial Infection, Linker Design and Synthesis, Antibiotic Synthesis, Antibody-antibiotic Conjugate, AAC in vitro Analysis, AAC in vivo Analysis.
There is no denying that monoclonal antibodies are potent tools for studying various disease owing to their high affinity and specificity, which also enable to track molecular as antibody based probes. By conjugating monoclonal antibodies with biophysical probes, technicians at Creative Biolabs can customize a series of antibody probes in terms of the specific requirements of clients, which can effectively track the distribution, transportation, and elimination of target molecular. At the same time, accurate and time-saving analysis services with high-quality biochemical analysis kits are also available to introduce different markers in cancer or other diseases.
“Our Ph.D. level scientists specialized in bioconjugation field have served numerous clients with their expertise. They deeply understand how to customize a suitable plan even if what our clients asked is a tough problem,” said the scientist at Creative Biolabs.
More details on bioconjugation services can be reached at https://www.creative-biolabs.com/adc.
About Creative Biolabs
With more than a decade of exploration and expansion, Creative Biolabs provides current research and service capacity that covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials. As an international cooperation, Creative Biolabs established offices all around the globe with more than 200 well-trained full-time scientists and technicians, who work closely with customers and research partners to develop new medicines for a better, healthier world. After years of pursuit for perfection, Creative Biolabs has established leadership in bioconjugation services. They offer customers comprehensive one-stop-shop of all aspects in research and evaluation, ranging from antigen selection, antibody production/optimization, and conjugation.